Stock Price
7.25
Daily Change
0.35 5.07%
Monthly
44.71%
Yearly
85.90%
Q1 Forecast
6.76

Silence Therapeutics reported $23.68M in Operating Expenses for its fiscal quarter ending in September of 2024.





Operating Expenses Change Date
AstraZeneca USD 12.53B 4.16B Dec/2025
Autolus Therapeutics Ltd USD 92.82M 10.21M Sep/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Novartis USD 9.86B 115M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Silence Therapeutics USD 23.68M 4.76M Sep/2024